The Allergy Immunotherapy Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of the allergy immunotherapy has experienced swift growth lately. In 2024, it was $2.88 billion and is projected to increase to $3.17 billion in 2025, with a compound annual growth rate (CAGR) of 10.2%. The historical growth trend in the Allergy Immunotherapy market shows a significant rise.
By 2029, the allergy immunotherapy market size is projected to reach $5.07 billion, with a compound annual growth rate (CAGR) of 12.4%.
Download Your Free Sample of the 2025 Allergy Immunotherapy Market Report and Uncover Key Trends Now!The key drivers in the allergy immunotherapy market are:
• Rising global allergy burden
• Healthcare policy support and increasing acceptance of immunotherapy
• Emergence of new markets and untapped regions
• Increasing healthcare expenditure
The allergy immunotherapy market covered in this report is segmented –
1) By Allergy Type: Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, Other Allergy Types
2) By Treatment: Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy, Specific Immunotherapy (SIT)
3) By Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
The key trends in the allergy immunotherapy market are:
• Advancements in immunotherapy treatment technology is shaping the future of the market.
• An increasing prevalence of allergies is affecting market trends.
• There is a growing trend of enhanced patient awareness and education.
• The use of telemedicine and remote monitoring, along with customized treatment plans, is influencing the market's future direction.
Major companies in the allergy immunotherapy market are:
• LETI Pharma
• Stallergenes Greer International AG
• Allergy Therapeutics plc
• ALK-Abelló A/S
• HAL Allergy B.V.
• DBV Technologies
• Circassia Pharmaceuticals Inc.
• Jubilant HollisterStier LLC
• Allergopharma GmbH & Co. KG
• Biomay AG
• Anergis SA
• HollisterStier Allergy
• Mylan N.V.
• Adamis Pharmaceuticals Corporation
• Desentum Oy
• WOLW Pharma Limited
• AllerGenics Inc.
• Greer Laboratories Inc.
• Aimmune Therapeutics Inc.
• Reliant Laboratories Inc.
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories Inc.
• Danaher Corporation
• QIAGEN NV
• Merck & Co. Inc.
• Pfizer Inc.
• Novartis AG
• GlaxoSmithKline plc
• AstraZeneca plc
• Sanofi SA
• Teva Pharmaceutical Industries Ltd.
• Endo Pharmaceuticals Inc.
• Sun Pharmaceutical Industries Ltd.
• Cipla Ltd.
Europe was the largest region in the allergy immunotherapy market in 2024